← Back to Search

Procedure

Mixed-reality tracheostomy tube change system for Tracheostomy Care (TRACHEAS Trial)

N/A
Waitlist Available
Led By Vinciya Pandian, PhD, MBA, MSN, RN, ACNP-BC
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Those who received a tracheostomy during their hospital stay
Those who were admitted to the hospital with a tracheostomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up an average of 6 weeks
Awards & highlights

TRACHEAS Trial Summary

This trial aims to test a new toolkit called NextGen Tracheostomy Toolkit in people who have undergone a tracheostomy. The trial will compare different groups of participants to see the effect of

Who is the study for?
This trial is for individuals who have a tracheostomy, which is an opening surgically created through the neck into the windpipe to allow direct access to the breathing tube. The study will include people who are currently requiring care for their tracheostomy.Check my eligibility
What is being tested?
The trial tests three interventions: an automated robotic suctioning device, a mixed-reality system for changing tracheostomy tubes, and a comprehensive NextGen Tracheostomy Toolkit that includes both devices. Participants will be randomly divided into four groups to compare these new technologies against standard tracheostomy care.See study design
What are the potential side effects?
Potential side effects may include discomfort or complications during suctioning or tube changes such as bleeding, infection risk increase due to equipment use, and possible technical issues with the new devices leading to interrupted care.

TRACHEAS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a tracheostomy during my hospital stay.
Select...
I was hospitalized and had a tracheostomy.

TRACHEAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~an average of 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and an average of 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Successful first-time tracheostomy tube changes
Percent of Successful Atraumatic suctionings
Secondary outcome measures
Discomfort as assessed by a Visual Analog Pain Scale
Discomfort as assessed by the Wong-Baker FACES Pain Rating Scale
Duration of mechanical ventilation
+12 more

TRACHEAS Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: NextGen Tracheostomy ToolkitExperimental Treatment1 Intervention
Participants in this group will receive tracheostomy care using the NextGen Tracheostomy Toolkit. Providers will be trained using virtual reality educational modules. Participants in this group will receive tracheostomy suctioning using an automated robotic suctioning device and tracheostomy tube changes using a mixed-reality tracheostomy tube change device.
Group II: Mixed-reality tracheostomy tube change systemExperimental Treatment1 Intervention
Participants in this group will receive tracheostomy tube changes using a mixed-reality tracheostomy tube change device.
Group III: Automated tracheostomy suctioning deviceExperimental Treatment1 Intervention
Participants in this group will receive tracheostomy suctioning using an automated robotic suctioning device.
Group IV: Control groupActive Control1 Intervention
Participants in this group will receive usual tracheostomy care.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,820,043 Total Patients Enrolled
Vinciya Pandian, PhD, MBA, MSN, RN, ACNP-BCPrincipal InvestigatorJohns Hopkins University School of Nursing
Michael J Brenner, MD, FACSPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to partake in this medical study?

"To be considered for participation in this research study, individuals must require tracheostomy care and fall within the age range of 18 to 100. The trial is currently accepting approximately 632 potential participants."

Answered by AI

Are potential participants still able to apply for enrollment in this ongoing research study?

"According to the information provided by clinicaltrials.gov, this particular clinical trial is not currently seeking participants. The trial was initially posted on October 1st, 2027 and last updated on January 24th, 2024. However, it's worth noting that there are four other ongoing clinical trials actively recruiting patients at the moment."

Answered by AI

Is the age criterion inclusive of individuals who have surpassed 70 years?

"As per the eligibility requirements outlined in this clinical trial, individuals between the ages of 18 and 100 are eligible for participation."

Answered by AI

What are the main goals being pursued in this research endeavor?

"The primary aim of this trial is to assess the percentage of successful atraumatic suctionings within an average duration of 6 weeks. Secondary objectives include evaluating tracheostomy duration, which refers to the length of time that the tracheostomy tube remains in place indicating dependence on tracheostomy; hospital length of stay, defined as the number of days spent in the hospital with a tracheostomy tube from insertion until discharge or removal; and identification and assessment of false tract occurrence during tracheostomy tube change procedure using various diagnostic methods such as capnography, pulsoximetry, and radiological findings."

Answered by AI
~421 spots leftby Jun 2029